Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift.

Hensley SE, Das SR, Bailey AL, Schmidt LM, Hickman HD, Jayaraman A, Viswanathan K, Raman R, Sasisekharan R, Bennink JR, Yewdell JW.

Science. 2009 Oct 30;326(5953):734-6. doi: 10.1126/science.1178258.

PMID:
19900932
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice.

O'Donnell CD, Vogel L, Wright A, Das SR, Wrammert J, Li GM, McCausland M, Zheng NY, Yewdell JW, Ahmed R, Wilson PC, Subbarao K.

MBio. 2012 May 29;3(3). pii: e00120-12. doi: 10.1128/mBio.00120-12. Print 2012.

PMID:
22647789
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection.

Das SR, Hensley SE, Ince WL, Brooke CB, Subba A, Delboy MG, Russ G, Gibbs JS, Bennink JR, Yewdell JW.

Cell Host Microbe. 2013 Mar 13;13(3):314-23. doi: 10.1016/j.chom.2013.02.008.

PMID:
23498956
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Epitope mapping of the hemagglutinin molecule of A/(H1N1)pdm09 influenza virus by using monoclonal antibody escape mutants.

Matsuzaki Y, Sugawara K, Nakauchi M, Takahashi Y, Onodera T, Tsunetsugu-Yokota Y, Matsumura T, Ato M, Kobayashi K, Shimotai Y, Mizuta K, Hongo S, Tashiro M, Nobusawa E.

J Virol. 2014 Nov;88(21):12364-73. doi: 10.1128/JVI.01381-14. Epub 2014 Aug 13.

PMID:
25122788
[PubMed - indexed for MEDLINE]
5.

Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.

Lambkin R, McLain L, Jones SE, Aldridge SL, Dimmock NJ.

J Gen Virol. 1994 Dec;75 ( Pt 12):3493-502.

PMID:
7527838
[PubMed - indexed for MEDLINE]
Free Article
6.

Monoclonal antibodies specific for discontinuous epitopes direct refolding of influenza A virus hemagglutinin.

Yewdell JW.

Mol Immunol. 2010 Feb;47(5):1132-6. doi: 10.1016/j.molimm.2009.10.023. Epub 2010 Jan 4.

PMID:
20047763
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin.

Schmeisser F, Friedman R, Besho J, Lugovtsev V, Soto J, Wang W, Weiss C, Williams O, Xie H, Ye Z, Weir JP.

Influenza Other Respir Viruses. 2013 May;7(3):480-90. doi: 10.1111/irv.12029. Epub 2012 Nov 5.

PMID:
23122228
[PubMed - indexed for MEDLINE]
8.

Evolution of the hemagglutinin protein of the new pandemic H1N1 influenza virus: maintaining optimal receptor binding by compensatory substitutions.

de Vries RP, de Vries E, Martínez-Romero C, McBride R, van Kuppeveld FJ, Rottier PJ, García-Sastre A, Paulson JC, de Haan CA.

J Virol. 2013 Dec;87(24):13868-77. doi: 10.1128/JVI.01955-13. Epub 2013 Oct 9.

PMID:
24109242
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Monoclonal antibodies differentially affect the interaction between the hemagglutinin of H9 influenza virus escape mutants and sialic receptors.

Ilyushina N, Rudneva I, Gambaryan A, Bovin N, Kaverin N.

Virology. 2004 Nov 10;329(1):33-9.

PMID:
15476872
[PubMed - indexed for MEDLINE]
Free Article
10.

Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity.

Yang ZY, Wei CJ, Kong WP, Wu L, Xu L, Smith DF, Nabel GJ.

Science. 2007 Aug 10;317(5839):825-8.

PMID:
17690300
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Escape mutants of pandemic influenza A/H1N1 2009 virus: variations in antigenic specificity and receptor affinity of the hemagglutinin.

Rudneva I, Ignatieva A, Timofeeva T, Shilov A, Kushch A, Masalova O, Klimova R, Bovin N, Mochalova L, Kaverin N.

Virus Res. 2012 Jun;166(1-2):61-7. doi: 10.1016/j.virusres.2012.03.003. Epub 2012 Mar 21.

PMID:
22459010
[PubMed - indexed for MEDLINE]
12.

Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.

Margine I, Krammer F, Hai R, Heaton NS, Tan GS, Andrews SA, Runstadler JA, Wilson PC, Albrecht RA, García-Sastre A, Palese P.

J Virol. 2013 Oct;87(19):10435-46. doi: 10.1128/JVI.01715-13. Epub 2013 Jul 31.

PMID:
23903831
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering.

Li Y, Bostick DL, Sullivan CB, Myers JL, Griesemer SB, Stgeorge K, Plotkin JB, Hensley SE.

J Virol. 2013 Sep;87(17):9904-10. doi: 10.1128/JVI.01023-13. Epub 2013 Jul 3.

PMID:
23824816
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Immunization with a low dose of hemagglutinin-encoding plasmid protects against 2009 H1N1 pandemic influenza virus in mice.

Fang J, Chen Z, Liu X, Li H, Wang J, Shen X, Chen W, Liu Y, Wang Y, Zhao P, Qi Z.

J Virol Methods. 2011 May;173(2):314-9. doi: 10.1016/j.jviromet.2011.03.001. Epub 2011 Mar 12.

PMID:
21392537
[PubMed - indexed for MEDLINE]
15.

Characterization of an enhanced antigenic change in the pandemic 2009 H1N1 influenza virus haemagglutinin.

García-Barreno B, Delgado T, Benito S, Casas I, Pozo F, Cuevas MT, Mas V, Trento A, Rodriguez-Frandsen A, Falcón A, Ortín J, Nieto A, Melero JA.

J Gen Virol. 2014 May;95(Pt 5):1033-42. doi: 10.1099/vir.0.061598-0. Epub 2014 Feb 14.

PMID:
24531414
[PubMed - indexed for MEDLINE]
16.

Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice.

Wanzeck K, Boyd KL, McCullers JA.

Am J Respir Crit Care Med. 2011 Mar 15;183(6):767-73. doi: 10.1164/rccm.201007-1184OC. Epub 2010 Oct 8.

PMID:
20935106
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

[Amino acid substitutions in the hemagglutinin of H5 influenza virus changing the antigenic specificity and virus virulence].

Krylov PS, Rudneva IA, Timofeeva TA, Shilov AA, Ignat'eva AV, Govorkova EA, Kaverin NV.

Vopr Virusol. 2009 Sep-Oct;54(5):14-9. Russian.

PMID:
19882897
[PubMed - indexed for MEDLINE]
18.

Induction of broadly neutralizing H1N1 influenza antibodies by vaccination.

Wei CJ, Boyington JC, McTamney PM, Kong WP, Pearce MB, Xu L, Andersen H, Rao S, Tumpey TM, Yang ZY, Nabel GJ.

Science. 2010 Aug 27;329(5995):1060-4. doi: 10.1126/science.1192517. Epub 2010 Jul 15.

PMID:
20647428
[PubMed - indexed for MEDLINE]
Free Article
19.

Antigenic sites of H1N1 influenza virus hemagglutinin revealed by natural isolates and inhibition assays.

Huang JW, Lin WF, Yang JM.

Vaccine. 2012 Sep 28;30(44):6327-37. doi: 10.1016/j.vaccine.2012.07.079. Epub 2012 Aug 8.

PMID:
22885274
[PubMed - indexed for MEDLINE]
20.

[Monoclonal antibodies with high virus-neutralizing activity against pandemic influenza virus A/llV-Moscow/01/2009 (H1N1)swl].

Klimova RR, Masalova OV, Burtseva EI, Chichev EV, Lesnova EI, Oskerko TA, Mukasheva EA, Rudneva IA, Lvov DK, Kushch AA.

Vopr Virusol. 2011 May-Jun;56(3):15-20. Russian.

PMID:
21786621
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk